BioMarin Pharmaceutical Inc. is a company in the U.S. stock market and it is a holding in 102 U.S.-traded ETFs. BMRN has around 13.9M shares in the U.S. ETF market. The largest ETF holder of BMRN is the Invesco QQQ Trust (QQQ), with approximately 1.95M shares. Investors may also find of interest that the ETF with the largest allocation to BMRN stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 5.48%. On average, U.S. ETFs allocate 0.50% of BMRN to their portfolios.
Additionally, BMRN is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BMRN as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.